Solid-State NMR of Viral Fusion Peptides and Proteins
Solid-State NMR of Viral Fusion Peptides and Proteins
批准号:
9512067
负责人:
David P Weliky
金额:
$31.78万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-30 至 2018-06-30
关键词:
Acquired Immunodeficiency SyndromeAdoptedAmino Acid SequenceBindingCatalysisCell membraneCellsChemicalsChimeric ProteinsCholesterolComplexDataDetergentsDevelopmentDiffusionDiseaseGoalsHIVHIV Envelope Protein gp120HIV vaccineHelix-Turn-Helix MotifsHemagglutininHydrocarbonsHydrophobicityImpairmentIn VitroInfectionInfluenzaIntegral Membrane ProteinIntracellular MembranesKineticsLabelLengthLigationLipidsLocationMagnetic ResonanceMeasurementMembraneMembrane FusionMembrane ProteinsModelingMole the mammalMutationN-terminalPeptidesPharmaceutical PreparationsPhysiologicalPlayPopulationPopulation DistributionsPrincipal InvestigatorProcessProtein RegionProteinsRegistriesRelaxationResearchRotationSNAP receptorSamplingSequence HomologySignal TransductionStructureTechniquesTertiary Protein StructureTestingTherapeuticTransmembrane DomainVertebral columnViralViral Fusion ProteinsViral VaccinesVirusVirus DiseasesWaterWorkbasebeta pleated sheetcomparativedesignendosome membranefunctional disabilityhuman diseaseinfluenzavirusinsightloss of functionmimeticsmonomermutantnovelpeptide Bpeptide chemical synthesispeptide structurepreferenceprogramsprototypereceptorsolid state nuclear magnetic resonancevaccine developmentvirus envelope
中文摘要
项目总监/主要研究者(最后一位、第一位、中间一位):Weliky,大卫保罗
项目总结/摘要
拟议研究的长期目标是详细了解病毒融合蛋白的基础-
诱导膜融合。病毒和靶细胞膜的融合是许多病毒感染的关键步骤
重要的疾病和融合机制的详细了解将有助于抗病毒药物的开发,
其作用方式是融合抑制的治疗剂。融合蛋白也是病毒疫苗的靶点
发展本研究的重点是研究血凝素HA 2和gp 41的融合蛋白。
流感病毒和人类免疫缺陷病毒。选择这些蛋白质是因为
病毒引起主要的人类疾病,因为这些蛋白质是其他I类病毒的原型,
融合蛋白虽然蛋白质序列是非同源的,但两种蛋白质都是单程的
病毒膜的跨膜蛋白,具有约180个残基的胞外域区域,位于膜外,
病毒特别强调的是~25个残基的N-末端“融合肽”(FP)结构域,其起着
在融合催化中起关键作用,并被认为在融合过程的早期插入宿主细胞膜。
存在四个目的,其包括HA 2(目的1)和gp 41(目的2)的FP的膜中的结构,以及
HA 2(目标3)和gp 41(目标4)的FP的膜位置。每个目标分为(a)仅FP和
(b)FP+可溶性胞外域+跨膜结构域切片。两种蛋白质的FP都可以采用α
螺旋或反平行β折叠结构,并且两种结构都催化膜融合。该项目的重点是
α HA 2和β gp 41 FP结构。结构/功能相关性进一步发展与推论
对HA 2 G1 E和gp 41 V2 E突变体的测量结果表明,这两种突变体均导致融合和病毒感染大大受损。
感染阐明FP结构和膜接触的主要技术是固态核磁共振
特别强调旋转回波双共振(REDOR),
阐明了核间的邻近性和距离≤ 10 μ m。REDOR将用于确定螺旋间HA 2 FP
结构和β gp 41 FP结构的反平行登记。将确定部分人群,
不同的结构以及结构和群体如何随着融合损害突变而变化。
将对FP/膜接触进行REDOR测量以及补充SSNMR
使用顺磁弛豫和1H自旋扩散测量FP/水接触。
OMB编号0925-0001/0002(2016年3月修订版,批准至2018年10月31日)
英文摘要
Program Director/Principal Investigator (Last, First, Middle): Weliky, David Paul
Project Summary/Abstract
The long-term goal of the proposed research is detailed understanding of the basis for viral fusion protein-
induced membrane fusion. Fusion of viral and target cell membranes is a key step in infection for many viruses
important in disease and a detailed understanding of fusion mechanisms will aid development of anti-viral
therapeutics whose mode of action is fusion inhibition. Fusion proteins are also a target of viral vaccine
development. The proposed research focuses on the hemagglutinin HA2 and gp41 fusion proteins of the
influenza virus and human immunodeficiency virus, respectively. These proteins are chosen because these
viruses cause major human diseases and because the proteins serve as prototypes for other class I viral
fusion proteins. Although the protein sequences are non-homologous, both proteins are single-pass
transmembrane proteins of the viral membrane with ~180-residue ectodomain regions which lie outside the
virus. There is particular emphasis on the ~25-residue N-terminal “fusion peptide” (FP) domain which plays a
key role in fusion catalysis and is thought to insert into the host cell membrane early in the fusion process.
There are four Aims which include structures in membrane of the FP's of HA2(Aim 1), and gp41(Aim 2), and
the membrane locations of the FP's of HA2(Aim 3) and gp41(Aim 4). Each Aim is divided into (a) FP-only and
(b) FP+soluble ectodomain+transmembrane domain sections. The FP's of both proteins can adopt either α
helical or antiparallel β sheet structure, and both structures catalyze membrane fusion. The project focuses on
the α HA2 and β gp41 FP structures. Structure/function correlations are further developed with corollary
measurements on HA2 G1E and gp41 V2E mutants which both result in greatly impaired fusion and viral
infection. The main technique to elucidate FP structure and membrane contacts is solid-state nuclear magnetic
resonance(SSNMR) with particular emphasis on rotational-echo double resonance(REDOR) which can
elucidate internuclear proximities and distances ≤10Å. REDOR will be used to determine interhelical HA2 FP
structures and antiparallel registries of β gp41 FP structures. Fractional populations will be determined for the
different structures as well as how the structures and populations change with fusion-impairing mutations.
There will be REDOR measurements of FP/membrane contacts as well as complementary SSNMR
measurements of FP/water contacts using paramagnetic relaxation and 1H spin diffusion.
OMB No. 0925-0001/0002 (Rev. 03/16 Approved Through 10/31/2018) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:8068086
-
项目类别:
-
资助金额:$10.23万
-
财政年份:2010
-
负责人:David P Weliky
-
依托单位:
Solid State NMR Studies of the HIV-1 Fusion Peptide
-
批准号:6628069
-
项目类别:
-
资助金额:$26.13万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:7048792
-
项目类别:
-
资助金额:$25.17万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid State NMR Studies of the HIV-1 Fusion Peptide
-
批准号:6847839
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:8416356
-
项目类别:
-
资助金额:$30.79万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid State NMR Studies of the HIV-1 Fusion Peptide
-
批准号:6698010
-
项目类别:
-
资助金额:$24.02万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid State NMR Studies of the HIV-1 Fusion Peptide
-
批准号:6332121
-
项目类别:
-
资助金额:$14.19万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:8209021
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:8050402
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:7157007
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid State NMR Studies of the HIV-1 Fusion Peptide
-
批准号:6497375
-
项目类别:
-
资助金额:$26.04万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:7559663
-
项目类别:
-
资助金额:$26.95万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:8605492
-
项目类别:
-
资助金额:$32.67万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:8789345
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:7342783
-
项目类别:
-
资助金额:$27.08万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:7754887
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2001
-
负责人:David P Weliky
-
依托单位:
Solid-State NMR of Viral Fusion Peptides and Proteins
-
批准号:10208665
-
项目类别:
-
资助金额:$35.73万
-
财政年份:2000
-
负责人:David P Weliky
-
依托单位:
SOLID STATE NMR STUDIES OF THE HIV-1 FUSION PEPTIDE
-
批准号:6086400
-
项目类别:
-
资助金额:$22.59万
-
财政年份:2000
-
负责人:David P Weliky
-
依托单位:
海外基金